Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Pregnancy Hypertension|June 7, 2020
Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsiaSunitha Suresh, Ariel Mueller, Saira Salahuddin, et al.
Pregnancy Hypertension|March 11, 2018
Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platformSiaw Li Chan, Sarosh Rana, Sireesha Chinthala, et al.
Hypertension in Pregnancy|September 11, 2012
Circulating lymphangiogenic factors in preeclampsiaA Titia Lely, Saira Salahuddin, Kim M Holwerda, et al.
Hypertension in Pregnancy|March 31, 2016
KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomesSaira Salahuddin, Julia B Wenger, Dongsheng Zhang, et al.
American Journal of Obstetrics and Gynecology|July 10, 2007
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancySaira Salahuddin, Young Lee, Mary Vadnais, et al.
Hypertension in Pregnancy|January 10, 2017
Relationship between hypoxia and downstream pathogenic pathways in preeclampsiaHenri Augusto Korkes, Leandro De Oliveira, Nelson Sass, et al.
Pregnancy Hypertension|September 5, 2018
Angiogenic biomarkers in triage and risk for preeclampsia with severe featuresSarosh Rana, Saira Salahuddin, Ariel Mueller, et al.
Hypertension in Pregnancy|July 12, 2019
Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsiaAi-Ris Yonekura Collier, Zsuzsanna Zsengeller, Elizabeth Pernicone, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 25, 2009
The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndromeBrett Young, Richard J Levine, Saira Salahuddin, et al.
The American Journal of Pathology|October 14, 2018
AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia PathogenesisAmbart E Covarrubias, Edouard Lecarpentier, Agnes Lo, et al.
Pageof 5